PI3K inhibitor GSK2126458, Purity ≥98%

Cat. No.: X24-05-ZQ023

PI3K inhibitor GSK2126458, Purity ≥98%

Synonym: 1086062-66-9; GSK-2126458; Omipalisib; PI3K inhibitor

  • CAS Number: 1086062-66-9
  • Compound CID: 25167777
Product Size
2 mg; 5 mg; 10 mg; 50 mg
Price
Datasheet
MSDS
Properties
Description
GSK2126458, soluble in DMSO and insoluble in ethanol and water, is a potent compound that inhibits PI3 kinase activity. It targets p110δ, p110γ, mTORC1, mTORC2, p110α, and p110β.
Molecular Weight
505.5
Molecular Formula
C25H17F2N5O3S
Targets
p110δ: 0.024 nM (Ki); p110γ: 0.06 nM (Ki); mTORC1: 0.18 nM (Ki); mTORC2: 0.3 nM (Ki); p110α: 0.019 nM (Ki); p110β: 0.13 nM (Ki)
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: 96 mg/mL (189.91 mM); Water: Insoluble; Ethanol: Insoluble
Identity
Confirmed by NMR/HPLC/MS.
Applications
GSK2126458 can be used to investigate dual PI3K/mTOR inhibition for potential anticancer therapy.
Related Products

Thanksgiving 2024

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0